Tanzania

previous Print
HIV/AIDS Statistics for Tanzania

Total population in thousands (2007): 40,454*
Number of people living with HIV (2007): 1,400,000*
Adults aged 15 and up living with HIV (2007): 1,300,000*
Women aged 15 and up living with HIV (2007): 760,000*
Deaths due to AIDS (2007): 96,000*
Ongoing biomedical HIV prevention research trials in Tanzania
Vaccines Microbicides

Vaccines

Trial: RV262
Phase: I
Start Date: September 2010
Sponsor, funder, developer: NIAID
Total participants: 92
Vaccine(s): Prime: PENNVAX-G DNA (ENV & GAG) Administered by Intramuscular Biojector 2000 or CELLECTRA Intramuscular Electroporation Device Boost: MVA-CMDR (HIV-1 CM235 ENV/CM240 GAG/POL)
Clade: A, B, C, D, E

Trial: TaMoVac 1
Phase: I/II
Start Date: June 2010
Sponsor, funder, developer: EDCTP, MUCHS, SMI, MHRP, University of Munich, Imperial College
Total participants: 120
Vaccine(s): Prime: HIVIS-DNA, Boost: MVA- CMDR
Clade: A, B, C

Back to Top ↑

Microbicides

Trial: Dapivirine vaginal ring safety [IPM 015]
Phase: I/II
Product Being Tested: Dapivirine vaginal ring
Sponsor, funder, developer, collaborator: International Partnership for Microbicides
Total participants: 280
Countries: South Africa, Kenya, Malawi, Rwanda, Tanzania
Results expected: n/a
For more information: http://www.clinicaltrials.gov/ct2/show/NCT01071174?term=dapivirine+vaginal+ring&rank=1
Back to Top ↑

*WHO, UNAIDS, and UNICEF. Epidemiological Fact Sheet on HIV and AIDS: Core data on epidemiological and response Tanzania 2008 Update. 2008. http://apps.who.int/globalatlas/predefinedReports/EFS2008/full/EFS2008_TZ.pdf